Part of the highly regarded Specialty Imaging series, this fully updated second edition by Drs. Santiago Martínez-Jiménez, Melissa L. Rosado-de-Christenson, and Brett W. Carter, reflects the many recent changes in HRCT diagnostic interpretation. An easy-to-read bulleted format and state of the art imaging examples guide you step-by-step through every aspect of thin-section CT and HRCT in the evaluation of patients with suspected lung disease. This book is an ideal resource for radiologists who need an easily accessible tool to help them understand the indications, strengths, and limitations of HRCT in their practice.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. DEDICATIONS - p. iii 6. CONTRIBUTING AUTHORS - p. v 7. PREFACE - p. v 8. ACKNOWLEDGMENTS - p. ix 9. SECTIONS - p. xi 10. SECTION 1: FUNDAMENTALS OF HRCT - p. xiii 11. Chapter 1: Overview of HRCT - p. xiii 12. Chapter 2: Approach to HRCT Interpretation - p. 7 13. ANATOMY - p. 13 14. Chapter 3: Secondary Pulmonary Lobule - p. 13 15. Chapter 4: Gravitational Changes (Dependent Atelectasis) - p. 17 16. Chapter 5: Age-Related (Senescent) Changes - p. 19 17. Chapter 6: Normal Inspiration and Expiration - p. 23 18. TERMINOLOGY AND SIGNS - p. 27 19. Chapter 7: Micronodules - p. 27 20. Chapter 8: Acinar Nodules - p. 28 21. Chapter 9: Tree-in-Bud Opacities - p. 29 22. Chapter 10: Ground-Glass Attenuation - p. 30 23. Chapter 11: Crazy-Paving Pattern - p. 31 24. Chapter 12: Mosaic Attenuation Pattern and Air-Trapping - p. 32 25. Chapter 13: Head Cheese Sign - p. 33 26. Chapter 14: Signet Ring Sign - p. 34 27. Chapter 15: Halo Sign - p. 35 28. Chapter 16: Reversed Halo Sign - p. 36 29. Chapter 17: Finger-in-Glove Sign - p. 37 30. Chapter 18: Honeycombing - p. 38 31. Chapter 19: Cystic Lung Disease - p. 39 32. Chapter 20: Flame-Shaped Nodules - p. 40 33. DISTRIBUTION - p. 41 34. Chapter 21: Peribronchovascular - p. 41 35. Chapter 22: Centrilobular - p. 45 36. Chapter 23: Perilymphatic - p. 49 37. Chapter 24: Random - p. 53 38. Chapter 25: Peripheral - p. 54 39. SECTION 2: PATHOLOGICAL PATTERNS OF INJURY - p. 55 40. Chapter 26: Approach to Pathological Patterns of Injury - p. 55 41. Chapter 27: Diffuse Alveolar Damage - p. 61 42. Chapter 28: Diffuse Alveolar Hemorrhage With Capillaritis - p. 65 43. Chapter 29: Organizing Pneumonia - p. 69 44. Chapter 30: Constrictive Bronchiolitis - p. 73 45. SECTION 3: LARGE AIRWAYS DISEASE - p. 77 46. Chapter 31: Approach to Large Airways Disease - p. 77 47. Chapter 32: Bronchiectasis - p. 81 48. Chapter 33: Allergic Bronchopulmonary Aspergillosis - p. 85 49. Chapter 34: Williams-Campbell Syndrome - p. 89 50. Chapter 35: Mounier-Kuhn Syndrome - p. 91 51. Chapter 36: Bronchocentric Granulomatosis - p. 93 52. SECTION 4: SMALL AIRWAYS DISEASE - p. 97 53. Chapter 37: Approach to Small Airways Disease - p. 97 54. Chapter 38: Infectious Bronchiolitis - p. 101 55. Chapter 39: Diffuse Aspiration Bronchiolitis - p. 105 56. Chapter 40: Respiratory Bronchiolitis - p. 109 57. Chapter 41: Follicular Bronchiolitis - p. 111 58. Chapter 42: Hypersensitivity Pneumonitis - p. 115 59. Chapter 43: Diffuse Panbronchiolitis - p. 121 60. Chapter 44: Idiopathic Constrictive Bronchiolitis - p. 123 61. Chapter 45: Swyer-James-MacLeod Syndrome - p. 127 62. Chapter 46: Bronchiolitis Obliterans Syndrome - p. 131 63. Chapter 47: Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) - p. 135 64. SECTION 5: INFECTION - p. 139 65. Chapter 48: Approach to Infection - p. 139 66. Chapter 49: Bacterial Pneumonia - p. 145 67. Chapter 50: Parasitic Infection - p. 149 68. Chapter 51: Viral Pneumonia - p. 155 69. Chapter 52: Invasive Aspergillosis - p. 159 70. Chapter 53: Pneumocystis Pneumonia - p. 163 71. Chapter 54: Tuberculosis - p. 167 72. Chapter 55: Nontuberculous Mycobacterial Infection - p. 173 73. SECTION 6: PNEUMOCONIOSIS - p. 179 74. Chapter 56: Approach to Pneumoconiosis - p. 179 75. Chapter 57: Silicosis and Coal Worker’s Pneumoconiosis - p. 183 76. Chapter 58: Asbestosis - p. 187 77. Chapter 59: Berylliosis - p. 193 78. Chapter 60: Talcosis - p. 197 79. Chapter 61: Hard-Metal Pneumoconiosis - p. 201 80. SECTION 7: NEOPLASMS - p. 203 81. Chapter 62: Approach to Neoplasms - p. 203 82. Chapter 63: Invasive Mucinous Adenocarcinoma (Diffuse) - p. 209 83. Chapter 64: Lymphangitic Carcinomatosis - p. 213 84. Chapter 65: Hematogenous Metastases - p. 217 85. Chapter 66: Endovascular Metastases and Tumor Emboli - p. 221 86. Chapter 67: Kaposi Sarcoma - p. 225 87. Chapter 68: Lymphangioleiomyomatosis - p. 229 88. Chapter 69: Reactive Lymphoproliferative Disorders - p. 233 89. Chapter 70: Neoplastic Lymphoproliferative Disorders - p. 239 90. SECTION 8: INTERSTITIAL PNEUMONIAS - p. 245 91. Chapter 71: Approach to Interstitial Pneumonias - p. 245 92. Chapter 72: Idiopathic Pulmonary Fibrosis - p. 251 93. Chapter 73: Idiopathic Nonspecific Interstitial Pneumonia - p. 257 94. Chapter 74: Cryptogenic Organizing Pneumonia - p. 261 95. Chapter 75: Acute Exacerbation of Interstitial Lung Disease - p. 265 96. Chapter 76: Acute Interstitial Pneumonia - p. 269 97. Chapter 77: Idiopathic Lymphoid Interstitial Pneumonia - p. 273 98. Chapter 78: Pleuropulmonary Fibroelastosis - p. 277 99. Chapter 79: Airway-Centered Interstitial Fibrosis - p. 281 100. Chapter 80: Interstitial Pneumonia With Autoimmune Features (IPAF) - p. 285 101. Chapter 81: Approach to Smoking-Related Interstitial Lung Diseases - p. 291 102. Chapter 82: Respiratory Bronchiolitis-Interstitial Lung Disease - p. 295 103. Chapter 83: Desquamative Interstitial Pneumonia - p. 297 104. Chapter 84: Combined Pulmonary Fibrosis and Emphysema - p. 301 105. SECTION 9: AUTOIMMUNE DISEASES - p. 305 106. Chapter 85: Approach to Connective Tissue Disease-Associated Interstitial Lung Disease - p. 305 107. Chapter 86: Rheumatoid Arthritis - p. 311 108. Chapter 87: Progressive Systemic Sclerosis - p. 315 109. Chapter 88: Dermatomyositis/Polymyositis - p. 319 110. Chapter 89: Sjögren Syndrome - p. 323 111. Chapter 90: Mixed Connective Tissue Disease - p. 329 112. Chapter 91: Systemic Lupus Erythematosus - p. 331 113. Chapter 92: Granulomatosis With Polyangiitis (GPA) - p. 337 114. Chapter 93: Eosinophilic Granulomatosis With Polyangiitis - p. 343 115. Chapter 94: Microscopic Polyangiitis - p. 347 116. Chapter 95: Ankylosing Spondylitis - p. 349 117. Chapter 96: Inflammatory Bowel Disease - p. 353 118. SECTION 10: VASCULAR DISEASE - p. 357 119. Chapter 97: Approach to Vascular Disease - p. 357 120. Chapter 98: Pulmonary Edema - p. 361 121. Chapter 99: Hepatopulmonary Syndrome - p. 367 122. Chapter 100: Pulmonary Hypertension - p. 369 123. Chapter 101: Pulmonary Venoocclusive Disease - p. 373 124. Chapter 102: Pulmonary Capillary Hemangiomatosis - p. 375 125. Chapter 103: Excipient Lung Disease (Talc/Cellulose Granulomatosis) - p. 377 126. SECTION 11: INHALATIONAL, INFLAMMATORY, METABOLIC, AND POST TREATMENT - p. 383 127. Chapter 104: Approach to Inhalational, Inflammatory, Metabolic, and Post Treatment - p. 383 128. ASPIRATION/INHALATION - p. 391 129. Chapter 105: Spectrum of Aspiration-Related Disorders - p. 391 130. Chapter 106: Lipoid Pneumonia - p. 395 131. Chapter 107: Inhalational Injury - p. 399 132. INFLAMMATORY - p. 403 133. Chapter 108: Sarcoidosis - p. 403 134. Chapter 109: Histiocytic Disorders - p. 409 135. Chapter 110: Eosinophilic Disorders - p. 415 136. METABOLIC OR DEGENERATIVE - p. 419 137. Chapter 111: Amyloidosis - p. 419 138. Chapter 112: Light-Chain Deposition Disease - p. 423 139. Chapter 113: Pulmonary Alveolar Proteinosis - p. 425 140. Chapter 114: Metastatic Pulmonary Calcification - p. 431 141. Chapter 115: Diffuse Pulmonary Ossification - p. 435 142. Chapter 116: Emphysema - p. 437 143. Chapter 117: Idiopathic Pulmonary Hemosiderosis - p. 441 144. POST TREATMENT - p. 443 145. Chapter 118: Radiation-Induced Lung Disease - p. 443 146. Chapter 119: Drug-Induced Lung Disease - p. 449 147. SECTION 12: CONGENITAL - p. 453 148. Chapter 120: Approach to Congenital - p. 453 149. Chapter 121: Familial Idiopathic Pulmonary Fibrosis - p. 461 150. Chapter 122: Birt-Hogg-Dubé Syndrome - p. 463 151. Chapter 123: Hermansky-Pudlak Syndrome - p. 465 152. Chapter 124: Tuberous Sclerosis - p. 467 153. Chapter 125: Neurofibromatosis - p. 471 154. Chapter 126: Alveolar Microlithiasis - p. 473 155. Chapter 127: α-1 Antitrypsin Deficiency - p. 475 156. Chapter 128: Primary Ciliary Dyskinesia - p. 477 157. Chapter 129: Primary Immunodeficiencies - p. 481 158. Chapter 130: Chronic Granulomatous Disease - p. 485 159. Chapter 131: Cystic Fibrosis - p. 487 160. Chapter 132: Childhood Interstitial Lung Disease (chILD) - p. 491 161. INDEX - p. 493
No hay muestra disponible
No hay ficha técnica disponible
Part of the highly regarded Specialty Imaging series, this fully updated second edition by Drs. Santiago Martínez-Jiménez, Melissa L. Rosado-de-Christenson, and Brett W. Carter, reflects the many recent changes in HRCT diagnostic interpretation. An easy-to-read bulleted format and state of the art imaging examples guide you step-by-step through every aspect of thin-section CT and HRCT in the evaluation of patients with suspected lung disease. This book is an ideal resource for radiologists who need an easily accessible tool to help them understand the indications, strengths, and limitations of HRCT in their practice.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. DEDICATIONS - p. iii 6. CONTRIBUTING AUTHORS - p. v 7. PREFACE - p. v 8. ACKNOWLEDGMENTS - p. ix 9. SECTIONS - p. xi 10. SECTION 1: FUNDAMENTALS OF HRCT - p. xiii 11. Chapter 1: Overview of HRCT - p. xiii 12. Chapter 2: Approach to HRCT Interpretation - p. 7 13. ANATOMY - p. 13 14. Chapter 3: Secondary Pulmonary Lobule - p. 13 15. Chapter 4: Gravitational Changes (Dependent Atelectasis) - p. 17 16. Chapter 5: Age-Related (Senescent) Changes - p. 19 17. Chapter 6: Normal Inspiration and Expiration - p. 23 18. TERMINOLOGY AND SIGNS - p. 27 19. Chapter 7: Micronodules - p. 27 20. Chapter 8: Acinar Nodules - p. 28 21. Chapter 9: Tree-in-Bud Opacities - p. 29 22. Chapter 10: Ground-Glass Attenuation - p. 30 23. Chapter 11: Crazy-Paving Pattern - p. 31 24. Chapter 12: Mosaic Attenuation Pattern and Air-Trapping - p. 32 25. Chapter 13: Head Cheese Sign - p. 33 26. Chapter 14: Signet Ring Sign - p. 34 27. Chapter 15: Halo Sign - p. 35 28. Chapter 16: Reversed Halo Sign - p. 36 29. Chapter 17: Finger-in-Glove Sign - p. 37 30. Chapter 18: Honeycombing - p. 38 31. Chapter 19: Cystic Lung Disease - p. 39 32. Chapter 20: Flame-Shaped Nodules - p. 40 33. DISTRIBUTION - p. 41 34. Chapter 21: Peribronchovascular - p. 41 35. Chapter 22: Centrilobular - p. 45 36. Chapter 23: Perilymphatic - p. 49 37. Chapter 24: Random - p. 53 38. Chapter 25: Peripheral - p. 54 39. SECTION 2: PATHOLOGICAL PATTERNS OF INJURY - p. 55 40. Chapter 26: Approach to Pathological Patterns of Injury - p. 55 41. Chapter 27: Diffuse Alveolar Damage - p. 61 42. Chapter 28: Diffuse Alveolar Hemorrhage With Capillaritis - p. 65 43. Chapter 29: Organizing Pneumonia - p. 69 44. Chapter 30: Constrictive Bronchiolitis - p. 73 45. SECTION 3: LARGE AIRWAYS DISEASE - p. 77 46. Chapter 31: Approach to Large Airways Disease - p. 77 47. Chapter 32: Bronchiectasis - p. 81 48. Chapter 33: Allergic Bronchopulmonary Aspergillosis - p. 85 49. Chapter 34: Williams-Campbell Syndrome - p. 89 50. Chapter 35: Mounier-Kuhn Syndrome - p. 91 51. Chapter 36: Bronchocentric Granulomatosis - p. 93 52. SECTION 4: SMALL AIRWAYS DISEASE - p. 97 53. Chapter 37: Approach to Small Airways Disease - p. 97 54. Chapter 38: Infectious Bronchiolitis - p. 101 55. Chapter 39: Diffuse Aspiration Bronchiolitis - p. 105 56. Chapter 40: Respiratory Bronchiolitis - p. 109 57. Chapter 41: Follicular Bronchiolitis - p. 111 58. Chapter 42: Hypersensitivity Pneumonitis - p. 115 59. Chapter 43: Diffuse Panbronchiolitis - p. 121 60. Chapter 44: Idiopathic Constrictive Bronchiolitis - p. 123 61. Chapter 45: Swyer-James-MacLeod Syndrome - p. 127 62. Chapter 46: Bronchiolitis Obliterans Syndrome - p. 131 63. Chapter 47: Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) - p. 135 64. SECTION 5: INFECTION - p. 139 65. Chapter 48: Approach to Infection - p. 139 66. Chapter 49: Bacterial Pneumonia - p. 145 67. Chapter 50: Parasitic Infection - p. 149 68. Chapter 51: Viral Pneumonia - p. 155 69. Chapter 52: Invasive Aspergillosis - p. 159 70. Chapter 53: Pneumocystis Pneumonia - p. 163 71. Chapter 54: Tuberculosis - p. 167 72. Chapter 55: Nontuberculous Mycobacterial Infection - p. 173 73. SECTION 6: PNEUMOCONIOSIS - p. 179 74. Chapter 56: Approach to Pneumoconiosis - p. 179 75. Chapter 57: Silicosis and Coal Worker’s Pneumoconiosis - p. 183 76. Chapter 58: Asbestosis - p. 187 77. Chapter 59: Berylliosis - p. 193 78. Chapter 60: Talcosis - p. 197 79. Chapter 61: Hard-Metal Pneumoconiosis - p. 201 80. SECTION 7: NEOPLASMS - p. 203 81. Chapter 62: Approach to Neoplasms - p. 203 82. Chapter 63: Invasive Mucinous Adenocarcinoma (Diffuse) - p. 209 83. Chapter 64: Lymphangitic Carcinomatosis - p. 213 84. Chapter 65: Hematogenous Metastases - p. 217 85. Chapter 66: Endovascular Metastases and Tumor Emboli - p. 221 86. Chapter 67: Kaposi Sarcoma - p. 225 87. Chapter 68: Lymphangioleiomyomatosis - p. 229 88. Chapter 69: Reactive Lymphoproliferative Disorders - p. 233 89. Chapter 70: Neoplastic Lymphoproliferative Disorders - p. 239 90. SECTION 8: INTERSTITIAL PNEUMONIAS - p. 245 91. Chapter 71: Approach to Interstitial Pneumonias - p. 245 92. Chapter 72: Idiopathic Pulmonary Fibrosis - p. 251 93. Chapter 73: Idiopathic Nonspecific Interstitial Pneumonia - p. 257 94. Chapter 74: Cryptogenic Organizing Pneumonia - p. 261 95. Chapter 75: Acute Exacerbation of Interstitial Lung Disease - p. 265 96. Chapter 76: Acute Interstitial Pneumonia - p. 269 97. Chapter 77: Idiopathic Lymphoid Interstitial Pneumonia - p. 273 98. Chapter 78: Pleuropulmonary Fibroelastosis - p. 277 99. Chapter 79: Airway-Centered Interstitial Fibrosis - p. 281 100. Chapter 80: Interstitial Pneumonia With Autoimmune Features (IPAF) - p. 285 101. Chapter 81: Approach to Smoking-Related Interstitial Lung Diseases - p. 291 102. Chapter 82: Respiratory Bronchiolitis-Interstitial Lung Disease - p. 295 103. Chapter 83: Desquamative Interstitial Pneumonia - p. 297 104. Chapter 84: Combined Pulmonary Fibrosis and Emphysema - p. 301 105. SECTION 9: AUTOIMMUNE DISEASES - p. 305 106. Chapter 85: Approach to Connective Tissue Disease-Associated Interstitial Lung Disease - p. 305 107. Chapter 86: Rheumatoid Arthritis - p. 311 108. Chapter 87: Progressive Systemic Sclerosis - p. 315 109. Chapter 88: Dermatomyositis/Polymyositis - p. 319 110. Chapter 89: Sjögren Syndrome - p. 323 111. Chapter 90: Mixed Connective Tissue Disease - p. 329 112. Chapter 91: Systemic Lupus Erythematosus - p. 331 113. Chapter 92: Granulomatosis With Polyangiitis (GPA) - p. 337 114. Chapter 93: Eosinophilic Granulomatosis With Polyangiitis - p. 343 115. Chapter 94: Microscopic Polyangiitis - p. 347 116. Chapter 95: Ankylosing Spondylitis - p. 349 117. Chapter 96: Inflammatory Bowel Disease - p. 353 118. SECTION 10: VASCULAR DISEASE - p. 357 119. Chapter 97: Approach to Vascular Disease - p. 357 120. Chapter 98: Pulmonary Edema - p. 361 121. Chapter 99: Hepatopulmonary Syndrome - p. 367 122. Chapter 100: Pulmonary Hypertension - p. 369 123. Chapter 101: Pulmonary Venoocclusive Disease - p. 373 124. Chapter 102: Pulmonary Capillary Hemangiomatosis - p. 375 125. Chapter 103: Excipient Lung Disease (Talc/Cellulose Granulomatosis) - p. 377 126. SECTION 11: INHALATIONAL, INFLAMMATORY, METABOLIC, AND POST TREATMENT - p. 383 127. Chapter 104: Approach to Inhalational, Inflammatory, Metabolic, and Post Treatment - p. 383 128. ASPIRATION/INHALATION - p. 391 129. Chapter 105: Spectrum of Aspiration-Related Disorders - p. 391 130. Chapter 106: Lipoid Pneumonia - p. 395 131. Chapter 107: Inhalational Injury - p. 399 132. INFLAMMATORY - p. 403 133. Chapter 108: Sarcoidosis - p. 403 134. Chapter 109: Histiocytic Disorders - p. 409 135. Chapter 110: Eosinophilic Disorders - p. 415 136. METABOLIC OR DEGENERATIVE - p. 419 137. Chapter 111: Amyloidosis - p. 419 138. Chapter 112: Light-Chain Deposition Disease - p. 423 139. Chapter 113: Pulmonary Alveolar Proteinosis - p. 425 140. Chapter 114: Metastatic Pulmonary Calcification - p. 431 141. Chapter 115: Diffuse Pulmonary Ossification - p. 435 142. Chapter 116: Emphysema - p. 437 143. Chapter 117: Idiopathic Pulmonary Hemosiderosis - p. 441 144. POST TREATMENT - p. 443 145. Chapter 118: Radiation-Induced Lung Disease - p. 443 146. Chapter 119: Drug-Induced Lung Disease - p. 449 147. SECTION 12: CONGENITAL - p. 453 148. Chapter 120: Approach to Congenital - p. 453 149. Chapter 121: Familial Idiopathic Pulmonary Fibrosis - p. 461 150. Chapter 122: Birt-Hogg-Dubé Syndrome - p. 463 151. Chapter 123: Hermansky-Pudlak Syndrome - p. 465 152. Chapter 124: Tuberous Sclerosis - p. 467 153. Chapter 125: Neurofibromatosis - p. 471 154. Chapter 126: Alveolar Microlithiasis - p. 473 155. Chapter 127: α-1 Antitrypsin Deficiency - p. 475 156. Chapter 128: Primary Ciliary Dyskinesia - p. 477 157. Chapter 129: Primary Immunodeficiencies - p. 481 158. Chapter 130: Chronic Granulomatous Disease - p. 485 159. Chapter 131: Cystic Fibrosis - p. 487 160. Chapter 132: Childhood Interstitial Lung Disease (chILD) - p. 491 161. INDEX - p. 493
No hay muestra disponible
No hay ficha técnica disponible
